Targeting siglecs—a novel pharmacological strategy for immuno-and glycotherapy

C Jandus, HU Simon, S von Gunten - Biochemical pharmacology, 2011 - Elsevier
The immune system must be tightly held in check to avoid bystander tissue damage as well
as autoreactivity caused by overwhelming immune reactions. A novel family of …
被引用次数：113 相关文章

Targeting siglecs--a novel pharmacological strategy for immuno-and glycotherapy.

C Jandus, HU Simon, S von Gunten - Biochemical pharmacology, 2011 - folia.unifr.ch
English The immune system must be tightly held in check to avoid bystander tissue damage
as well as autoreactivity caused by overwhelming immune reactions. A novel family of …

Targeting Siglecs—A novel pharmacological strategy for immuno-and glycotherapy

C Jandus, HU Simon, S von Gunten - Biochemical Pharmacology, 2011 - infona.pl
The immune system must be tightly held in check to avoid bystander tissue damage as well
as autoreactivity caused by overwhelming immune reactions. A novel family of …

Targeting siglecs--a novel pharmacological strategy for immuno-and glycotherapy.

C Jandus, HU Simon, S von Gunten - Biochemical pharmacology, 2011 - sonar.ch
English The immune system must be tightly held in check to avoid bystander tissue damage
as well as autoreactivity caused by overwhelming immune reactions. A novel family of …

Targeting siglecs--a novel pharmacological strategy for immuno-and glycotherapy

C Jandus, HU Simon, S von Gunten - Biochemical pharmacology, 2011 - boris.unibe.ch
The immune system must be tightly held in check to avoid bystander tissue damage as well
as autoreactivity caused by overwhelming immune reactions. A novel family of …

Targeting siglecs--a novel pharmacological strategy for immuno-and glycotherapy.

C Jandus, HU Simon, S von Gunten - Biochemical Pharmacology, 2011 - europepmc.org
The immune system must be tightly held in check to avoid bystander tissue damage as well
as autoreactivity caused by overwhelming immune reactions. A novel family of …

Targeting siglecs--a novel pharmacological strategy for immuno-and glycotherapy

C Jandus, HU Simon… - Biochemical …, 2011 - pubmed.ncbi.nlm.nih.gov
The immune system must be tightly held in check to avoid bystander tissue damage as well
as autoreactivity caused by overwhelming immune reactions. A novel family of …

[引用][C] Targeting Siglecs—A novel pharmacological strategy for immuno-and glycotherapy

C JANDUS, HU SIMON… - Biochemical …, 2011 - pascal-francis.inist.fr
Targeting Siglecs—A novel pharmacological strategy for immuno- and glycotherapy CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …

[引用][C] Targeting Siglecs—A novel pharmacological strategy for immuno-and glycotherapy

C JANDUS, HU SIMON, S VON GUNTEN - Biochemical pharmacology, 2011 - Elsevier